Cargando…

1091. Validation of an Allometrically Scaled Body Weight Equation to Predict Vancomycin Clearance and Guide 24-Hour Vancomycin AUC Dosing in Obese Patients

BACKGROUND: Accurately determining empiric vancomycin (VAN) doses in obese patients represents a clinical challenge. A recent population pharmacokinetic (PK) study provided an equation to estimate vancomycin clearance (CL) based on age, sex, serum creatinine (Scr), and allometrically scaled body wei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Footer, Brent, Nguyen, Arthur, Greckel, Meagan, Taylor, Colton, Christensen, Alyssa, Tallman, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644132/ http://dx.doi.org/10.1093/ofid/ofab466.1285

Ejemplares similares

1828. Dalbavancin Utilization and Associated Clinical Outcomes: A Case-Series
por: Greckel, Meagan N, et al.
Publicado: (2022)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

1599. AUC24 Vancomycin Bayesian-Based Dosing: Increasing Therapeutic Target Attainment with Decreased TDM Cost
por: Sabourenkov, Paul E, et al.
Publicado: (2019)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
por: Sujjavorakul, Kritsaporn, et al.
Publicado: (2023)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

Association between the AUC(0-24)/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis
por: Men, Peng, et al.
Publicado: (2016)

1576. Delaying the Start of Maintenance Vancomycin After a Loading Dose to Avoid a High 0–24h AUC
por: Lee, Judy T Y, et al.
Publicado: (2019)

Therapeutic drug monitoring of vancomycin by AUC(τ)-MIC ratio in patients with chronic kidney disease
por: Khoei, Ahmad, et al.
Publicado: (2019)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
por: Mcgrady, Kerri A., et al.
Publicado: (2020)

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing
por: Boyd, Allison N, et al.
Publicado: (2022)

397 Correlation between calculated vancomycin AUC(0-24)/MIC and acute kidney injury in patients with Methicillin Resistant Staphylococcus Aureus bacteraemia
por: Ghosh, Niladri, et al.
Publicado: (2014)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

2193. Vancomycin AUC:MIC Monitoring: Transitioning Safely from Inpatient to Outpatient Monitoring via OPAT
por: Campion, Maureen, et al.
Publicado: (2023)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
por: Seddon, Megan, et al.
Publicado: (2018)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
por: Hussain, Kashif, et al.
Publicado: (2022)

Successful Treatment of Invasive MRSA Infections in Children Using Area Under the Vancomycin Concentration-Time Curve Divided by the Minimum Inhibitory Concentration (AUC/MIC) to Measure Vancomycin Exposure
por: Chiang, Leslie, et al.
Publicado: (2021)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

1391. Vancomycin Area Under the Curve (AUC) to Predict Nephrotoxicity: A Systematic Review and Meta-Analysis of Observational Studies
por: Aljefri, Doaa, et al.
Publicado: (2018)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

Safety and Feasibility Assessment of a Pharmacy-Driven AUC/MIC Vancomycin Dosing Protocol in a Multicenter Hospital System
por: Phillips, Morgan, et al.
Publicado: (2023)

2226. Trough- Versus AUC-Based Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
por: Smith, Darrell, et al.
Publicado: (2023)

1326. Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
por: Pearson, Jeffrey, et al.
Publicado: (2020)

Detection of vancomycin resistances in enterococci within 3 ½ hours
por: -Ch. Schröder, U., et al.
Publicado: (2015)

1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
por: Avedissian, Sean, et al.
Publicado: (2018)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
por: Chen, Jihui, et al.
Publicado: (2021)

175. Assessment of Institutional Uptake of Vancomycin AUC Monitoring One-Year Post Guideline Publication in Hospitals Across the United States
por: Bradley, Nicole, et al.
Publicado: (2021)

2558. Association of Vancomycin-Induced Acute Kidney Injury with Trough Versus AUC Monitoring in Patients Receiving Extended Durations of Therapy
por: Pitcock, C Tyler, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rst7eh1hhfrjo325j2ll1e4cia